Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
May-2021 Volume 23 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2021 Volume 23 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway

  • Authors:
    • Shao Ouyang
    • Wei Chen
    • Zeng Gaofeng
    • Lei Changcheng
    • Tian Guoping
    • Zhu Minyan
    • Liu Yang
    • Yang Min
    • Jiahao Luo
  • View Affiliations / Copyright

    Affiliations: Department of Cardiovascular Medicine, The Second Affiliated Hospital, University of South China, Hengyang, Hunan 421001, P.R. China, Department of Respiratory Medicine, The Second Affiliated Hospital, University of South China, Hengyang, Hunan 421001, P.R. China
    Copyright: © Ouyang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 338
    |
    Published online on: March 9, 2021
       https://doi.org/10.3892/mmr.2021.11977
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Pulmonary artery hypertension (PAH) is a disease with high morbidity and mortality. Cyanidin‑3‑O‑β‑glucoside (Cy‑3‑g), a classical anthocyanin, has a variety of biological effects. The present study evaluated whether Cy‑3‑g attenuated PAH, and explored the potential mechanism of action. Rats were injected with monocrotaline (MCT; 60 mg per kg of body weight) and then treated with Cy‑3‑g (200 or 400 mg per kg of body weight) for 4 weeks. Protein expression was determined in vitro in transforming growth factor‑β1 (TGF‑β1)‑mediated human pulmonary arterial smooth muscle cells (SMCs). The results indicated that Cy‑3‑g significantly inhibited the mean pulmonary artery pressure, right ventricular systolic pressure and right ventricular hypertrophy index, as well as vascular remodeling induced by MCT in PAH rats. Further experiments showed that Cy‑3‑g suppressed the expression of pro‑­inflammatory factors and enhanced the levels of anti‑inflammatory factors. Cy‑3‑g blocked oxidative stress and improved vascular endothelial injury. Cy‑3‑g also reduced the proliferation of SMCs. Furthermore, the MCT‑ and TGF‑β1‑induced increase in TGF‑β1, phosphorylated (p)‑p38 mitogen‑activated protein kinase (MAPK) and p‑cAMP‑response element binding protein (CREB) expression was blocked by Cy‑3‑g treatment in vivo and in vitro. These results indicated that Cy‑3‑g could prevent vascular remodeling in PAH via inhibition of the TGF‑β1/p38 MAPK/CREB axis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Vender RL: Chronic hypoxic pulmonary hypertension. Chest. 106:236–243. 1994. View Article : Google Scholar : PubMed/NCBI

2 

Greyson CR: Pathophysiology of right ventricular failure. Crit Care Med. 36 (Suppl 1):S57–S65. 2018. View Article : Google Scholar

3 

Humbert M, Morrell NW, Archer SL, Stenmark KP, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel FN and Rabinovitch M: Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 43 (Suppl 12):S13–S24. 2014. View Article : Google Scholar

4 

Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, et al: Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol. 54 (Suppl 1):S20–S31. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Tuder RM, Archer SL, Dorfmuller P, Erzurum SC, Guignabert C, Michelakis E, Rabinovitch M, Schermuly R, Stenmark KR and Morrell NW: Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol. 62 (Suppl 25):D4–D12. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Peacock AJ, Murphy NF, McMurray JJ, Caballero L and Stewart S: An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 30:104–109. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Montani D, Chaumais MC, Guignabert C, Günther S, Girerd B, Jaïs X, Algalarrondo V, Price LC, Savale L, Sitbon O, et al: Targeted therapies in pulmonary arterial hypertension. Pharmacol Ther. 141:172–191. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Rabinovitch M, Guignabert C, Humbert M and Nicolls MR: Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 115:165–175. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Ahmed LA, Obaid AA, Zaki HF and Agha AM: Role of oxidative stress, inflammation, nitric oxide and transforming growth factor-beta in the protective effect of diosgenin in monocrotaline-induced pulmonary hypertension in rats. Eur J Pharmacol. 740:379–387. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Satoh K, Satoh T, Kikuchi N, Omura J, Kurosawa R, Suzuki K, Sugimura K, Aoki T, Nochioka K, Tatebe S, et al: Basigin mediates pulmonary hypertension by promoting inflammation and vascular smooth muscle cell proliferation. Circ Res. 115:738–750. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Zhang Y and Wu S: Effects of fasudil on pulmonary hypertension in clinical practice. Pulm Pharmacol Ther. 46:54–63. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Liu C, Fang C, Cao G, Liu K, Wang B, Wan Z, Li S and Wu S: Ethyl pyruvate ameliorates monocrotaline-induced pulmonary arterial hypertension in rats. J Cardiovasc Pharmacol. 64:7–15. 2017. View Article : Google Scholar

13 

Balabanian K, Foussat A, Dorfmüller P, Durand-Gasselin I, Capel F, Bouchet-Delbos L, Portier A, Marfaing-Koka A, Krzysiek R, Rimaniol AC, et al: CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med. 165:1419–1425. 2002. View Article : Google Scholar : PubMed/NCBI

14 

Zhang Q, Fan K, Wang P, Yu J, Liu R, Qi H, Sun H and Cao Y: Carvacrol induces the apoptosis of pulmonary artery smooth muscle cells under hypoxia. Eur J Pharmacol. 770:134–146. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Liu Y and Hu CN: Effects of Maher BbeChatain on the expression of transforming growth factor-1 and connective tissue growth factor in diabetic rats. Chin J Geriat Med. 34:6691–6693. 2014.

16 

Joshua DS, Andrew WH and Jackson R: AMP-activated protein kinase inhibits transforming growth factor-β-mediated vascular smooth muscle cell growth: Implications for a Smad-3-dependent mechanism. Am J Physiol Heart Circ Physiol. 309:H1251–H1259. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Kwon IS, Yim JH, Lee HK and Pyo S: Lobaric acid inhibits VCAM-1 expression in TNF-α-etimulated vascular smooth muscle cells via modulation of NF-κB and MAPK signaling pathways. Biomol Ther (Seoul). 24:25–32. 2016. View Article : Google Scholar : PubMed/NCBI

18 

Xu Y, Gu Q and Qu C: Capsaicin pretreatment reversed pulmonary arterial hypertension by alleviating inflammation via p38MAPK pathway. Ex Lung Res. 43:8–18. 2017. View Article : Google Scholar

19 

Ding M, Feng R, Wang SY, Bowman L, Lu Y, Qian Y, Castranova V, Jiang BL and Shi X: Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J Biol Chem. 281:17359–17368. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Fang J: Bioavailability of anthocyanins. Drug Metab Rev. 46:508–520. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Kong JM, Chia LS, Goh NK, Chia TF and Brouillard R: Analysis and biological activities of anthocyanins. Phytochemistry. 64:923–933. 2008. View Article : Google Scholar

22 

Herath HM, Takano-Ishikawa Y and Yamaki K: Inhibitory effect of some flavonoids on tumor necrosis factor-alpha production in lipopolysaccharide-stimulated mouse macrophage cell line J774.1. J Med Food. 6:365–370. 2003. View Article : Google Scholar : PubMed/NCBI

23 

Xia XD, Ling WH, Ma J, Xia M, Hou MJ, Wang Q, Zhu HL and Tang ZH: Anthocyanin-rich extract from black rice enhances atherosclerotic slaque stabilization in apolipoprotein E-deficient mice. J Nutr. 136:2220–2225. 2006. View Article : Google Scholar : PubMed/NCBI

24 

Wang DL, Wei X, Yan X, Jin T and Ling WH: Protocatechuic acid, a metabolite of anthocyanins, inhibits monocyte adhesion and reduces atherosclerosis in apolipoprotein E-deficient mice. J Agric Food Chem. 58:12722–12728. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Liu Y, Wang X, Pang J, Zhang HY, Luo J, Qian XY, Chen Q and Ling WH: Attenuation of atherosclerosis by protocatechuic acid via inhibition of M1 and promotion of M2 macrophage polarization. J Agric Food Chem. 67:807–818. 2019. View Article : Google Scholar : PubMed/NCBI

26 

Dell'Agli M, Busciala A and Bosisio E: Vascular effects of wine polyphenols. Cardiovasc Res. 63:593–602. 2004. View Article : Google Scholar : PubMed/NCBI

27 

Xia M, Ling WH, Zhu HL, Ma J, Wang Q, Hou MJ, Tang ZH, Guo HH, Liu C and Ye QY: Anthocyanin attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation. Atherosclerosis. 202:41–47. 2009. View Article : Google Scholar : PubMed/NCBI

28 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

29 

Mao GX, Zheng LD, Cao YB, Chen ZM, Lv YD, Wang YZ, Hu XL, Wang GF and Yan J: Antiaging effect of pine pollen in human diploid fibroblasts and in a mouse model induced by D-Galactose. Oxid Med Cell Longev. 2012:7509632012. View Article : Google Scholar : PubMed/NCBI

30 

Kylhammar D, Hesselstrand R, Nielsen S, Scheele C and Rådegran G: Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension. Scand J Rheumatol. 47:319–324. 2018. View Article : Google Scholar : PubMed/NCBI

31 

Appelmann I, Liersch R, Kessler T, Mesters RM and Berdel WE: Angiogenesis inhibition in cancer therapy: Platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: Biological functions and role in malignancy. Recent Results Cancer Res. 180:51–81. 2010. View Article : Google Scholar : PubMed/NCBI

32 

Zhu N, Zhao X, Xiang Y, Ye S, Huang J, Hu W, Lv L and Zeng C: Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats. Int J Cardiol. 221:587–596. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Maarman G, Lecour S, Butrous G, Thienemann F and Sliwa K: A comprehensive review: The evolution of animal models in pulmonary hypertension research; are we there yet? Pulm Circ. 3:739–756. 2013. View Article : Google Scholar : PubMed/NCBI

34 

Wang D, Zou T, Yang Y, Yan X and Ling W: Cyanidin-3-O-β-glucoside with the aid of its metabolite protocatechuic acid, reduces monocyte infiltration in apolipoprotein E-deficient mice. Biochem. Pharmacol. 7:713–719. 2011.

35 

Yan XR, Wu L, Li B, Meng XJ, Dai HP, Zheng YN and Fu JF: Cyanidin-3-O-glucoside attenuates acute lung injury in sepsis rats. J Surg Res. 199:592–600. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Qian XY, Wang X, Luo J, Liu Y, Pang J, Zhang HY, Xu ZL, Xie JW, Jiang XW and Ling WH: Hypouricemic and nephroprotective roles of anthocyanins in hyperuricemic mice. Food Func. 10:867–878. 2019. View Article : Google Scholar

37 

Joppa P, Petrasova D, Stancak B and Tkacova R: Systemic inflammation in patients with COPD and pulmonary hypertension. Chest. 130:326–333. 2006. View Article : Google Scholar : PubMed/NCBI

38 

Price LC, Wort SJ, Perros F, Dorfmuller P, Huertas A, Montani D, Cohen-Kaminsky S and Humbert M: Inflammation in pulmonary arterial hypertension. Chest. 141:210–221. 2012. View Article : Google Scholar : PubMed/NCBI

39 

Fukumoto Y: Role of the Rho-kinase pathway in pulmonary arterial hypertension. Nihon Yakurigaku Zasshi. 143:178–181. 2014.(In Japanese). View Article : Google Scholar : PubMed/NCBI

40 

Irarrázaval S, Allard J, Campodónico J, Perez D, Strobel P, Vasquez L, Urquiaga I, Echeverria G and Leighton F: Oxidative stress in acute hypobaric hypoxia. High Alt Med Biol. 18:128–134. 2017. View Article : Google Scholar : PubMed/NCBI

41 

Chen J, Wang YX, Dong MQ, Zhang B, Luo Y, Niu W and Li ZC: Reoxygenation reverses hypoxic pulmonary arterial remodeling by inducing smooth muscle cell apoptosis via reactive oxygen species-mediated mitochondrial dysfunction. Am Heart Assoc. 6:e0056022017.

42 

Suresh K, Servinsky L, Jiang HY, Bigham Z, Yun X, Kliment C, Huetsch J, Damarla M and Shimoda LA: Reactive oxygen species induced Ca2+ influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 314:L893–L907. 2018. View Article : Google Scholar : PubMed/NCBI

43 

Zeng JW, Chen BY, Lv XF, Sun L, Zeng XL, Zheng HQ, Du YH, Wang GL, Ma MM and Guan YY: Transmembrane member 16A participates in hydrogen peroxide-induced apoptosis by facilitating mitochondria-dependent pathway in vascular smooth muscle cells. Br J Pharmacol. 175:3669–3684. 2018. View Article : Google Scholar : PubMed/NCBI

44 

Hisayama T, Inomoto M, Hioki Y and Fukui H: Identification of PKC isozymes and effect of knockdown of PKC alpha by antisense oligodeoxynucleotide on iNOS expression via interleukin-1 receptor in vascular smooth muscle cells. Nihon Yakurigaku Zasshi. 114 (Suppl 1):86P–91P. 1999.(In Japanese). View Article : Google Scholar : PubMed/NCBI

45 

Fan Z, Liu B, Zhang S, Liu H, Li Y, Wang D, Liu Y, Li J, Wang N, Liu Y and Zhang B: YM155, a selective survivin inhibitor, reverses chronic hypoxic pulmonary hypertension in rats via upregulating voltage-gated potassium channels. Clin Exp Hypertens. 37:381–387. 2015. View Article : Google Scholar : PubMed/NCBI

46 

Manach C, Mazur A and Scalbert A: Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol. 16:77–84. 2005. View Article : Google Scholar : PubMed/NCBI

47 

Xia M, Hou M, Zhu H, Ma J, Tang Z, Wang Q, Li Y, Chi D, Yu X, Zhao T, et al: Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: The role of the peroxisome proliferator-activated receptor {gamma}-liver X receptor {alpha}-ABCA1 pathway. J Biol Chem. 280:36792–36801. 2005. View Article : Google Scholar : PubMed/NCBI

48 

Zhu Y, Xia M, Yang Y, Liu F, Li Z, Hao YT, Mi MT, Jin T and Ling WH: Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals. Clin Chem. 57:1524–1533. 2011. View Article : Google Scholar : PubMed/NCBI

49 

Edirisinghe I, Banaszewski K, Cappozzo J, McCarthy D and Burton-Freeman BM: Effect of black currant anthocyanins on the activation of endothelial nitric oxide synthase (eNOS) in vitro in human endothelial cells. J Agric Food Chem. 59:8616–8624. 2013. View Article : Google Scholar

50 

Sun XZ, Tian XY, Wang DW and Li J: Effects of fasudil on hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats. Eur Rev Med Pharmacol Sci. 18:959–964. 2014.PubMed/NCBI

51 

Sim JY: Nitric oxide and pulmonary hypertension. Korean J Anesthesiol. 58:4–14. 2010. View Article : Google Scholar : PubMed/NCBI

52 

Polonio IB, Acencio MM, Pazetti R, Almeida FM, Silva BS, Pereira KA and Souza R: Lodenafil treatment in the monocrotaline model of pulmonary hypertension in rats. J Bras Pneumol. 40:421–424. 2014.(In English, Portuguese). View Article : Google Scholar : PubMed/NCBI

53 

Satwiko MG, Ikeda K, Nakayama K, Yagi K, Hocher B, Hirata K and Emoto N: Targeted activation of endothelin-1 exacerbates hypoxia-induced pulmonary hypertension. Biochem Biophys Res Commun. 465:356–362. 2015. View Article : Google Scholar : PubMed/NCBI

54 

Wardle AJ, Seager MJ, Wardle R, Tulloh RM and Gibbs JS: Guanylate cyclase stimulators for pulmonary hypertension. Cochrane Database Syst Rev. 8:CD0112052016.

55 

Hoeper MM, McLaughlin VV, Dalaan AM, Satoh T and Galie N: Treatment of pulmonary hypertension. Lancet Respir Med. 4:323–336. 2016. View Article : Google Scholar : PubMed/NCBI

56 

Yu L, Tu Y, Jia X, Fang K, Liu L, Wan L, Xiang C, Wang Y, Sun X, Liu T, et al: Resveratrol protects against pulmonary arterial hypertension in rats via activation of silent information regulator 1. Cell Physiol Biochem. 42:55–67. 2017. View Article : Google Scholar : PubMed/NCBI

57 

Zhou S, Li MT, Jia YY, Liu JJ, Wang Q, Tian Z, Liu YT, Chen HZ, Liu DP and Zeng XF: Regulation of cell cycle regulators by SIRT1 contributes to resveratrol-mediated prevention of pulmonary arterial hypertension. Biomed Res Int. 2015:7623492015. View Article : Google Scholar : PubMed/NCBI

58 

Rashid S, Idris-Khodja N, Auger C, Kevers C, Pincemail J, Alhosin M, Boehm N, Oswald-Mammosser M and Schini-Kerth VB: Polyphenol-rich blackcurrant juice prevents endothelial dysfunction in the mesenteric artery of cirrhotic rats with portal hypertension: Role of oxidative stress and the angiotensin system. J Med Food. 21:390–399. 2018. View Article : Google Scholar : PubMed/NCBI

59 

Hua C, Zhao J, Wang H, Chen F, Meng H, Chen L, Zhang Q, Yan J and Yuan L: Apple polyphenol relieves hypoxia-induced pulmonary arterial hypertension via pulmonary endothelium protection and smooth muscle relaxation: In vivo and in vitro studies. Biomed Pharmacother. 107:937–944. 2018. View Article : Google Scholar : PubMed/NCBI

60 

Zhang N, Dong MQ, Luo Y, Zhao F and Li YJ: Danshensu prevents hypoxic pulmonary hypertension in rats by inhibiting the proliferation of pulmonary artery smooth muscle cells via TGF-β-smad3-associated pathway. Eur J Pharmacol. 820:1–7. 2018. View Article : Google Scholar : PubMed/NCBI

61 

Upton PD, Davies RJ, Tajsic T and Morrell NW: Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3. Am J Respir Cell Mol Biol. 49:1135–1145. 2013. View Article : Google Scholar : PubMed/NCBI

62 

Sheares KK, Jeffery TK, Long L and Morrell NW: Differential effects of TGF-beta1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 287:L919–L927. 2004. View Article : Google Scholar : PubMed/NCBI

63 

Ren X, Shi Y, Zhao D, Xu M, Li X, Dang Y and Ye X: Naringin protects ultraviolet B-induced skin damage by regulating p38MAPK signal pathway. J Dermatol Sci. 82:106–114. 2016. View Article : Google Scholar : PubMed/NCBI

64 

Chen X, Xiu M, Xing J, Yu S, Min D and Guo F: Lanthanum chloride inhibits LPS mediated expressions of pro-inflammatory cytokines and adhesion molecules in HUVECs: Involvement of NF-κB-Jmjd3 signaling. Cell Physiol Biochem. 42:1713–1724. 2017. View Article : Google Scholar : PubMed/NCBI

65 

Ge J, Zhang Y and Zhang ZZ: Research progress on CREB and the signal transduction by phosphorylation of CREB at serine 133. Cell. 59:675–680. 2009.

66 

Gonzallez GA and Montminy MR: Cyclic AMPs timulatessomatostat in gene transcription by phosphorylation of CREB at serine 133. Cell. 59:675–680. 2009. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ouyang S, Chen W, Gaofeng Z, Changcheng L, Guoping T, Minyan Z, Yang L, Min Y and Luo J: Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway. Mol Med Rep 23: 338, 2021.
APA
Ouyang, S., Chen, W., Gaofeng, Z., Changcheng, L., Guoping, T., Minyan, Z. ... Luo, J. (2021). Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway. Molecular Medicine Reports, 23, 338. https://doi.org/10.3892/mmr.2021.11977
MLA
Ouyang, S., Chen, W., Gaofeng, Z., Changcheng, L., Guoping, T., Minyan, Z., Yang, L., Min, Y., Luo, J."Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway". Molecular Medicine Reports 23.5 (2021): 338.
Chicago
Ouyang, S., Chen, W., Gaofeng, Z., Changcheng, L., Guoping, T., Minyan, Z., Yang, L., Min, Y., Luo, J."Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway". Molecular Medicine Reports 23, no. 5 (2021): 338. https://doi.org/10.3892/mmr.2021.11977
Copy and paste a formatted citation
x
Spandidos Publications style
Ouyang S, Chen W, Gaofeng Z, Changcheng L, Guoping T, Minyan Z, Yang L, Min Y and Luo J: Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway. Mol Med Rep 23: 338, 2021.
APA
Ouyang, S., Chen, W., Gaofeng, Z., Changcheng, L., Guoping, T., Minyan, Z. ... Luo, J. (2021). Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway. Molecular Medicine Reports, 23, 338. https://doi.org/10.3892/mmr.2021.11977
MLA
Ouyang, S., Chen, W., Gaofeng, Z., Changcheng, L., Guoping, T., Minyan, Z., Yang, L., Min, Y., Luo, J."Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway". Molecular Medicine Reports 23.5 (2021): 338.
Chicago
Ouyang, S., Chen, W., Gaofeng, Z., Changcheng, L., Guoping, T., Minyan, Z., Yang, L., Min, Y., Luo, J."Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway". Molecular Medicine Reports 23, no. 5 (2021): 338. https://doi.org/10.3892/mmr.2021.11977
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team